FitzGerald, L M <br/><br/>
Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases.  [electronic resource] 

 -  Prostate cancer and prostatic diseases  06 2018 
 - 228-237 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5608 
<br/><br/><label>Standard No.: </label>10.1038/s41391-017-0029-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Biomarkers, Tumor--genetics<br/>Clinical Trials as Topic<br/>Cohort Studies<br/>DNA Modification Methylases--genetics<br/>DNA Repair Enzymes--genetics<br/>Follow-Up Studies<br/>Germ-Line Mutation<br/>Humans<br/>Interleukin-4--genetics<br/>Male<br/>Middle Aged<br/>Polymorphism, Single Nucleotide<br/>Prognosis<br/>Prostatic Neoplasms--genetics<br/>Proto-Oncogene Proteins c-akt--genetics<br/>Survival Rate<br/>Tumor Suppressor Proteins--genetics